$271 Million is the total value of JGP Global Gestao de Recursos Ltda.'s 76 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRUSTcall | $84,744,000 | – | 300,000 | +100.0% | 31.32% | – |
| EEM | Buy | ISHARES MSCI EMERGING MARKETcall | $34,336,000 | +1658.1% | 800,000 | +1500.0% | 12.69% | +435.0% |
| EWZ | Buy | ISHARES MSCI BRAZIL ETFetp | $24,594,000 | +28.8% | 600,000 | +20.0% | 9.09% | -60.8% |
| SMH | New | VANECK VECTORS SEMICONDUCTORput | $21,266,000 | – | 200,000 | +100.0% | 7.86% | – |
| VALE | New | VALE SA-SP ADRadr | $17,703,000 | – | 1,355,527 | +100.0% | 6.54% | – |
| MELI | New | MERCADOLIBRE INC | $15,283,000 | – | 30,100 | +100.0% | 5.65% | – |
| EWZ | New | ISHARES MSCI BRAZIL ETFcall | $14,347,000 | – | 350,000 | +100.0% | 5.30% | – |
| STNE | New | STONECO LTD-Aput | $8,222,000 | – | 200,000 | +100.0% | 3.04% | – |
| OIBRC | Buy | OI SA-ADRadr | $6,100,000 | +34.8% | 3,244,559 | +14.8% | 2.26% | -59.0% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $1,610,000 | +9.7% | 6,512 | +10.5% | 0.60% | -66.6% |
| INCY | Buy | INCYTE CORP | $1,318,000 | +38.9% | 15,325 | +2.7% | 0.49% | -57.8% |
| STNE | New | STONECO LTD-Acall | $1,233,000 | – | 30,000 | +100.0% | 0.46% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $1,183,000 | +13.0% | 13,319 | +8.4% | 0.44% | -65.6% |
| ILMN | Buy | ILLUMINA INC | $1,002,000 | +14.5% | 3,224 | +10.5% | 0.37% | -65.2% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $943,000 | +20.6% | 7,914 | +10.4% | 0.35% | -63.3% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $924,000 | +47.1% | 6,837 | +6.0% | 0.34% | -55.2% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $873,000 | +83.0% | 5,487 | +10.1% | 0.32% | -44.2% |
| HUM | Buy | HUMANA INC | $600,000 | +2.4% | 2,257 | +10.4% | 0.22% | -68.8% |
| BLUE | Buy | BLUEBIRD BIO INC | $569,000 | +75.1% | 3,618 | +10.3% | 0.21% | -46.8% |
| EXAS | Buy | EXACT SCIENCES CORP | $561,000 | +51.6% | 6,479 | +10.5% | 0.21% | -53.9% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $553,000 | +1.3% | 11,599 | +10.5% | 0.20% | -69.2% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $520,000 | +19.8% | 13,561 | +10.5% | 0.19% | -63.6% |
| ABT | Buy | ABBOTT LABORATORIES | $510,000 | +22.0% | 6,384 | +10.4% | 0.19% | -63.0% |
| CI | Buy | CIGNA CORP | $506,000 | -6.5% | 3,148 | +10.5% | 0.19% | -71.5% |
| CNC | Buy | CENTENE CORP | $488,000 | +1.7% | 9,194 | +121.0% | 0.18% | -69.1% |
| CELG | Buy | CELGENE CORP | $474,000 | +62.3% | 5,029 | +10.5% | 0.18% | -50.7% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $467,000 | +38.2% | 2,439 | +10.5% | 0.17% | -57.8% |
| GWPH | Buy | GW PHARMACEUTICALS -ADRadr | $460,000 | +90.1% | 2,730 | +10.1% | 0.17% | -42.2% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $456,000 | +22.6% | 2,481 | +10.5% | 0.17% | -62.6% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $455,000 | +56.9% | 33,471 | +10.5% | 0.17% | -52.3% |
| DXCM | Buy | DEXCOM INC | $452,000 | +10.0% | 3,791 | +10.4% | 0.17% | -66.5% |
| EXEL | Buy | EXELIXIS INC | $452,000 | +33.3% | 18,973 | +10.2% | 0.17% | -59.5% |
| MRK | Buy | MERCK & CO. INC. | $433,000 | +20.3% | 5,208 | +10.4% | 0.16% | -63.4% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $405,000 | +45.2% | 8,523 | +10.4% | 0.15% | -55.8% |
| AGN | Buy | ALLERGAN PLC | $399,000 | +20.9% | 2,723 | +10.4% | 0.15% | -63.3% |
| LLY | Buy | ELI LILLY & CO | $377,000 | +24.0% | 2,908 | +10.5% | 0.14% | -62.3% |
| ANTM | Buy | ANTHEM INC | $373,000 | +20.7% | 1,300 | +10.5% | 0.14% | -63.2% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $337,000 | +42.2% | 6,370 | +10.5% | 0.12% | -56.6% |
| ABBV | Buy | ABBVIE INC | $308,000 | -3.1% | 3,817 | +10.5% | 0.11% | -70.5% |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $302,000 | -3.8% | 15,344 | +10.4% | 0.11% | -70.6% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $289,000 | +35.0% | 3,278 | +9.4% | 0.11% | -58.8% |
| ARGX | Buy | ARGENX SE - ADRadr | $286,000 | +41.6% | 2,288 | +9.0% | 0.11% | -56.7% |
| NTRA | Buy | NATERA INC | $279,000 | +63.2% | 13,518 | +10.5% | 0.10% | -50.5% |
| ALGN | New | ALIGN TECHNOLOGY INC | $267,000 | – | 939 | +100.0% | 0.10% | – |
| BOLD | New | AUDENTES THERAPEUTICS INC | $264,000 | – | 6,759 | +100.0% | 0.10% | – |
| NVRO | New | NEVRO CORP | $262,000 | – | 4,189 | +100.0% | 0.10% | – |
| IMMU | Buy | IMMUNOMEDICS INC | $252,000 | +49.1% | 13,097 | +10.5% | 0.09% | -54.6% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $249,000 | +21.5% | 606 | +10.6% | 0.09% | -63.1% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $247,000 | – | 9,203 | +100.0% | 0.09% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $243,000 | – | 426 | +100.0% | 0.09% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $242,000 | – | 3,296 | +100.0% | 0.09% | – |
| PRQR | Buy | PROQR THERAPEUTICS NV | $228,000 | -3.0% | 16,433 | +10.5% | 0.08% | -70.5% |
| BIIB | Buy | BIOGEN INC | $223,000 | -13.2% | 945 | +10.5% | 0.08% | -73.7% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $210,000 | +9.9% | 25,742 | +8.5% | 0.08% | -66.4% |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $207,000 | – | 1,651 | +100.0% | 0.08% | – |
| EPZM | Buy | EPIZYME INC | $170,000 | +123.7% | 13,691 | +10.4% | 0.06% | -31.5% |
| GLYC | New | GLYCOMIMETICS INC | $126,000 | – | 10,088 | +100.0% | 0.05% | – |
| DBVT | Buy | DBV TECHNOLOGIES SA-SPON ADRadr | $84,000 | +27.3% | 10,935 | +7.1% | 0.03% | -61.2% |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $55,000 | +10.0% | 13,880 | +10.4% | 0.02% | -67.2% |
| PTI | Buy | PROTEOSTASIS THERAPEUTICS IN | $28,000 | -56.2% | 21,871 | +10.5% | 0.01% | -87.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-04-24
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BMRN | 30 | Q3 2023 | 2.8% |
| INCYTE CORP | 28 | Q3 2023 | 3.9% |
| VERTEX PHARMACEUTICALS INC | 26 | Q3 2023 | 3.9% |
| LILLY ELI & CO | 26 | Q3 2023 | 1.3% |
| REGENERON PHARMACEUTICALS | 26 | Q3 2023 | 1.6% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2023 | 5.9% |
| ACADIA PHARMACEUTICALS INC | 24 | Q3 2023 | 0.7% |
| THERMO FISHER SCIENTIFIC INC | 21 | Q3 2023 | 4.7% |
| ABBVIE INC | 21 | Q3 2023 | 1.9% |
| HUMANA INC | 21 | Q3 2023 | 1.6% |
View JGP Global Gestao de Recursos Ltda.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-09 |
| 13F-HR | 2024-01-19 |
| 13F-HR | 2023-11-01 |
| 13F-HR | 2023-08-04 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-01-25 |
| 13F-HR | 2022-11-04 |
| 13F-HR | 2022-08-01 |
| 13F-HR | 2022-05-05 |
| SC 13G | 2022-02-11 |
View JGP Global Gestao de Recursos Ltda.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.